<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163770">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00966173</url>
  </required_header>
  <id_info>
    <org_study_id>6001</org_study_id>
    <nct_id>NCT00966173</nct_id>
  </id_info>
  <brief_title>International Melanoma Algorithm Training Study - IMATS</brief_title>
  <official_title>An International, Multicenter, Prospective, Non-controlled, Non-randomised, Clinical Study to Collect Impedance Data of Potentially Malignant Pigmented Nevi and Histological Diagnoses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SciBase AB</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SciBase AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an international, multicenter, prospective, non controlled, non randomized, clinical
      study to collect electrical impedance data of potentially malignant pigmented nevi and
      histological diagnoses (International Melanoma Algorithm Training Study [IMATS]). The study
      objective is to collect data for training and optimization of an algorithm that can classify
      skin lesions using electrical impedance, i.e., to identify malignant melanomas.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Outcome measure not applicable. This is an algorithm training study.</measure>
    <time_frame>Q1 2010</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>Malignant Melanoma</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SciBase III Electrical Impedance Spectrometer</intervention_name>
    <description>Following enrollment, patients will undergo measurements with SciBase III Electrical Impedance Spectrometer. Electrical impedance of the skin will be measured with a microinvasive spiked probe.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women of any ethnic group

          -  Lesion located on normal healthy skin

          -  Maximum number of eight lesions per patient

          -  etc.

        Exclusion Criteria:

          -  Lesion under finger and toe nails

          -  Lesion located on eczema, psoriasis areas or similar

          -  Lesion located on scars

          -  etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital, Dpt. of Dermatology</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <lastchanged_date>August 10, 2010</lastchanged_date>
  <firstreceived_date>August 25, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Anders Lundqvist, CEO</name_title>
    <organization>SciBase AB</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
